These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4115470)

  • 41. [Monoamine oxidase. 16. Purification of monoamine oxidase from beef liver mitochondria and its enzymatic properties].
    Arai Y; Matsumoto K; Kamijo K
    Nihon Yakurigaku Zasshi; 1972 Jul; 68(4):400-9. PubMed ID: 4144082
    [No Abstract]   [Full Text] [Related]  

  • 42. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ
    Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of some derivatives of piperidine, piperazine and related compounds on deamination of serotonin, tyramine and benzylamine by pig liver mitochondrial monoamine oxidase].
    Prikulis AA; Grinberga BA; Grinshteĭn VIa; Strelka GR
    Biokhimiia; 1983; 48(2):313-9. PubMed ID: 6838929
    [No Abstract]   [Full Text] [Related]  

  • 44. Physicochemical properties, development, and regulation of central and peripheral monoamine oxidase activity.
    Youdim MB; Holzbauer M; Woods HF
    Adv Biochem Psychopharmacol; 1974; 12(0):11-28. PubMed ID: 4608303
    [No Abstract]   [Full Text] [Related]  

  • 45. Amine competition for oxidation by rat liver mitochondrial monoamine oxidase.
    Houslay MD; Tipton KF
    Biochem Pharmacol; 1975 Mar; 24(5):627-31. PubMed ID: 1125064
    [No Abstract]   [Full Text] [Related]  

  • 46. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
    Murphy DL; Donnelly CH
    Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554
    [No Abstract]   [Full Text] [Related]  

  • 47. Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors.
    Krueger MJ; Mazouz F; Ramsay RR; Milcent R; Singer TP
    Biochem Biophys Res Commun; 1995 Jan; 206(2):556-62. PubMed ID: 7826372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hydrazine derivative modification of the activity of brain mitochondrial monoamine oxidases].
    Kalninia IE; Baumanas EA; Kaĭrane ChB; Gorkin VZ
    Vopr Med Khim; 1981; 27(6):773-9. PubMed ID: 7336653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoamine oxidase inhibitors.
    Ho BT
    J Pharm Sci; 1972 Jun; 61(6):821-37. PubMed ID: 4558257
    [No Abstract]   [Full Text] [Related]  

  • 51. Metabolic interaction of secondary amines and tertiary amino propiophenones with monoamine oxidase systems.
    Bangdiwala VS; Oswald EO
    Chem Biol Interact; 1976 Jul; 14(1-2):141-8. PubMed ID: 954134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoamine oxidase & amine-tetrazolium reductase in mitochondrial preparations.
    Haque SJ; Poddar MK
    Indian J Biochem Biophys; 1983 Apr; 20(2):100-3. PubMed ID: 6671661
    [No Abstract]   [Full Text] [Related]  

  • 53. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
    Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
    Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effect of hydrocortisone on oxidative deamination of biogenic amines in some parts of the brain and liver of rabbits].
    Balykina EM
    Fiziol Zh; 1972; 18(6):825-8. PubMed ID: 4659669
    [No Abstract]   [Full Text] [Related]  

  • 56. [In vivo and in vitro effect of N-morpholino-3-ethylamino-4 phenyl-6 pyridazine (Agr 620) on rat liver and brain mitochondrial monoamine oxidase].
    Thuret F; Lamothe C; Laborit H
    Agressologie; 1970; 11(5):417-20. PubMed ID: 5516969
    [No Abstract]   [Full Text] [Related]  

  • 57. Monoamine oxidase activities towards biogenic monoamines in several regions of rat brain.
    Harada M; Kondo Y; Kuzuya H; Nagatsu T
    J Neurochem; 1975 Jan; 24(1):193-5. PubMed ID: 1110362
    [No Abstract]   [Full Text] [Related]  

  • 58. Human liver mitochondrial monoamine oxidase. 3. Kinetic studies concerning time-dependent inhibitions.
    McEwen CM; Sasaki G; Jones DC
    Biochemistry; 1969 Oct; 8(10):3963-72. PubMed ID: 5346379
    [No Abstract]   [Full Text] [Related]  

  • 59. Proceedings: Age dependent recovery of rat brain MAO activity after administration of a single dose of iproniazid and pargyline.
    Sprengeler T; Rakow D; Schulze G; Christ W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R12. PubMed ID: 1143390
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanistic aspects of the oxidation of amines by monoamine oxidase.
    Oi S; Yasunobu KT
    Biochem Biophys Res Commun; 1973 Jul; 53(2):631-7. PubMed ID: 4737975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.